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Abstract (248 words) 
Objectives: National dietary guidelines were introduced in 1977 and 1983, by the United States 
(US) and United Kingdom (UK) governments to reduce coronary heart disease (CHD) mortality by 
reducing dietary fat intake. Our 2016 systematic review examined the epidemiological evidence 
available to the dietary committees at the time; we found no support for the recommendations to 
restrict dietary fat. The present investigation extends our work by re-examining the totality of 
epidemiological evidence currently available relating to dietary fat guidelines. 
Methods: A systematic review and meta-analysis of prospective cohort studies currently available, 
which examined the relationship between dietary fat, serum cholesterol and the development of 
CHD, were undertaken. 
Results: Across 7 studies, involving 89,801 participants (94% male), there were 2,024 deaths from 
CHD during the mean follow-up of 11.9 ± 5.6 years. The death rate from CHD was 2.25%. Eight 
data sets were suitable for inclusion in meta-analysis; all excluded participants with previous heart 
disease.  
Risk ratios (RR) from meta-analysis were not statistically significant for CHD deaths and total or 
saturated fat consumption. The risk ratio (RR) from meta-analysis for total fat intake and CHD 
deaths was 1.04 (95% CI 0.98 to 1.10). The RR from meta-analysis for saturated fat intake and 
CHD deaths was 1.08 (95% CI 0.94 to 1.25). 
Conclusions: Epidemiological evidence to date found no significant difference in CHD mortality 
and total fat or saturated fat intake and thus does not support the present dietary fat guidelines. The 
evidence per se lacks generalisability for population-wide guidelines. 
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Introduction 
US public health dietary advice was announced by the Select Committee on Nutrition and Human 
needs in 1977[1] and was followed by UK public health dietary advice issued by the National 
Advisory Committee on Nutritional Education in 1983.[2] Dietary recommendations in both cases 
focused on reducing dietary fat intake; specifically to i) reduce overall fat consumption to 30% of 
total energy intake and ii) reduce saturated fat consumption to 10% of total energy intake. 
The recommendations were intended to address mortality from coronary heart disease (CHD). In 
2015, we published a systematic review and meta-analysis,[3] which reported that evidence from 
randomised controlled trials (RCTs), available to the dietary guideline committees, did not support 
the introduced dietary fat recommendations. In 2016, we published a systematic review and meta-
analysis,[4] which reported that RCT evidence currently available does not support the introduced 
dietary guidelines. In 2016, we published a systematic review,[5] which reported that 
epidemiological evidence, available to the dietary guideline committees, did not support the 
introduced dietary fat recommendations. The aim of these systematic reviews has been twofold: to 
examine the epidemiological and RCT evidence base for the dietary fat guidelines to assess if they 
were justified at the time of their introduction and to review if the evidence currently available 
supports the extant recommendations. This systematic review and meta-analysis completes this 
work by examining the totality of epidemiological evidence currently available.  
Methods 
This systematic review and meta-analysis uses the Meta-analysis Of Observational Studies in 
Epidemiology methodology (MOOSE).[6] MOOSE uses parts of the Cochrane methodology for 
systematic review and meta-analysis of RCTs, Preferred Reporting Items for Systematic reviews 
and Meta-Analyses (PRISMA), for example the figure for presenting search methodology.[7] To 
examine best practice evidence available, this review has focused on prospective cohort studies.[8] 
Search strategy 
A search was undertaken to identify prospective cohort studies that examined the relationship 
between dietary fat intake, serum cholesterol and mortality from CHD. Exclusion criteria were: 
clinical trials; cross-sectional studies; case control studies. Inclusion criteria were: prospective 
cohort studies; participants were human adults; primary study outcome was CHD mortality; data 
related to dietary fat consumption were available; data on CHD mortality and serum cholesterol 
measurements were available. 
The search was undertaken on 30 September 2015. No date limitations were set, enabling the 
earliest possible papers to be included. Searches of the literature were performed using MEDLINE, 
Embase and the Cochrane Library (Fig. 1). 
Selection of studies 
Of 669 identified articles, 607 were rejected upon review of the title and abstract. Of these, 55 were 
rejected for being review articles. 55 were commentaries, editorials or letters. 39 were clinical trials, 
9 were cross sectional or case control studies. 75 related to conditions other than heart disease, 
primarily cancer, diabetes, hypertension and obesity. There were 53 studies in which animals or 
children/adolescents were the primary focus. 98 were articles about pharmacology/blood analysis. 
123 were rejected for being related to a particular food, nutrient or supplement, rather than dietary 
fat. A further 40 papers were educational material and 36 reviewed dietary compliance in nutritional 
studies. 24 articles were mathematical modelling exercises, including meta-analysis. 62 papers 
remained. 13 were rejected on closer inspection of the full paper: 12 were reviews, commentaries or 
expert opinion pieces and 1 was educational material. Where an abstract was unavailable, the 
publication type, journal name and meta-tags were reviewed to assess if the article should be 
rejected (for example “letter”, “clinical trial”, “paediatric”). Copies of the remaining articles were 
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obtained from university libraries or the British Library. 49 papers, prima facie, met the inclusion 
criteria. 
Of the 49 papers included in qualitative synthesis, 18 were found prima facie to meet the inclusion 
criteria and 31 were duplications of these 18 studies. On detailed examination of the 18 studies, 6 
were the studies included in Harcombe et al,[5] which were available to the UK National Advisory 
Committee in 1983. The Western Electric study;[9 10] The Puerto Rico Heart Health Program;[11-
13] The Seven Countries Study;[14] The Framingham Heart Study;[11 15] The Honolulu Heart 
Program;[11 16 17] and a study conducted in London and the South East.[18] None of these had 
data conducive to meta-analysis. 24 papers were additional publications related to these 6 studies; 
the majority of these were about The Seven Countries Study. The additional publications were 
examined for data published after the introduction of the dietary fat guidelines to assess if any 
Harcombe et al[5] studies could be updated. A 1984 paper about The Honolulu Heart Program[19] 
and a 1991 paper about The Framingham Heart Study[20] were reviewed, but neither reported CHD 
mortality. 
A total of 12 new studies were found.[21-32] Seven papers were additional publications related to 
these studies. Four studies were excluded on closer inspection for not reporting CHD mortality 
data[22 23 25 26] and another one contained CHD mortality data that were not separable from CHD 
events.[24] These five studies also failed to meet inclusion criteria for other reasons: no saturated 
fat data;[22 26] no total fat data;[25 26] no serum cholesterol data.[22-24 26] Mann et al was the 
only study to review animal fat, not all dietary fat.[26] This study, examining the benefits of a 
vegetarian diet, reported consumption of total animal fat and saturated animal fat, thus excluding 
the fat and saturated fat in many non-animal foods.[33] 
Six studies did not report serum cholesterol data,[21 27 28 30-32] which left one study meeting the 
full inclusion criteria.[29] The serum cholesterol component part of the diet-heart hypothesis was 
set aside as an inclusion criterion, which enabled data for dietary fat (total and saturated) and CHD 
mortality to be examined for seven studies.[21 27-32] The UK Health survey[21] presented data for 
men and women separately and The Strong Heart Study of American Indians[31] presented data for 
those aged 47-59 years and those aged 60-79 separately. Table 1 presents the extracted data for total 
and saturated dietary fat and CHD deaths for these seven studies; nine information sets. 
To ascertain the validity of eligible observational studies, a pair of reviewers (ZH and BD) worked 
independently to determine which studies met the inclusion criteria. The same one additional study 
was agreed upon as meeting the original diet-heart hypothesis criteria and the same seven studies 
were agreed upon for the revised search. One of the authors (ZH) examined contemporary 
systematic reviews of prospective cohort studies [34-36] to ensure that no studies had been omitted 
or included inconsistently. Correspondence was entered into with one author for thorough 
verification. [37] Risk of bias was assessed using the Cochrane Collaboration assessment tool for 
component parts relevant to observational studies, defined as follows: selection bias (cohort 
appropriately reflected wider population characteristics); detection bias (blinding of outcome 
assessment); attrition bias (incomplete data outcome); and reporting bias (selective reporting) (Fig. 
2).[38]  
Data Extraction 
Table 1 details data extraction of: study name; year of key publications; participant characteristics; 
whether free from CHD at study entry; years of follow-up; CHD deaths; outcomes relating to total 
dietary fat and saturated dietary fat for CHD deaths. 
Statistical Analysis 
The overall pooled effect was calculated using random effects meta-analysis. This takes into 
account between study variance when assigning weights in meta-analysis. The weighting of studies 
is more balanced with random effects than fixed effects methodology; larger studies have less 
impact and smaller studies have more impact than with fixed effects. Heterogeneity and bias were 
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quantified using the I² and T² calculations, I2 = 100%×(Q - df)/Q, where Q is Cochran's 
heterogeneity statistic and df the degrees of freedom. Funnel plot methodology and Egger's 
regression intercept[39 40] were calculated to assess risk of publication bias. Analyses were 
performed using Comprehensive Meta-Analysis.[41] 
Meta-analysis was possible for all but one study in Table 1.[27] Kushi et al reported fat intake as a 
percentage of overall energy intake for those who died from CHD and those who did not. However, 
no standard deviations or standard errors were presented, which are necessary for inclusion in meta-
analysis. Forest plots for the associations between CHD deaths and total fat and saturated fat are 
presented in Fig. 3 and Fig. 4 respectively. 
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Fig. 1 Summary of systematic review profile[7]. 
 
* The search undertaken was: ("coronary heart disease"[tiab] OR "ischaemic heart disease"[tiab]) 
AND ("diet"[tiab] OR "dietary"[tiab]) NOT ("clinical trial"[pt] OR "letter"[pt] OR "editorial"[pt] OR 
"review"[pt]) AND ("dietary fats"[nm] OR "cholesterol"[nm]). Publications were limited to those in 
English and involving humans; no other exclusions were made. 
Potentially relevant publications 
identified and screened for retrieval (n 
= 669) * 
Papers screened for more detailed 
evaluation (n = 669) 
Papers excluded for non-fulfilment of 
inclusion criteria: review articles (n = 
55); commentary/ editorial/letter (n = 
55); clinical trials (n = 39); cross 
sectional/case control studies (n = 9); 
focus on conditions other than CHD (n 
= 75); studies of animals/children (n = 
53); pharmacology/blood analysis (n = 
98); non-dietary fat study (n = 123); 
educational material/dietary compliance 
papers (n = 76); mathematical 
modelling (n = 24). 
Total (n = 607) 
 
Full-text articles assessed for eligibility 
 (n = 62) 
Papers excluded for non-fulfilment of 
inclusion criteria: review/commentary/ 
expert opinion articles (n = 12); 
educational material (n = 1). 
Total (n = 13) 
Studies included in qualitative synthesis 
(n = 49) 
Studies examined for data availability  
(n = 18) 
Papers of studies prima facie meeting 
criteria (n = 18); duplication of these 
studies (n = 31). 
Total (n = 31) 
 
Studies meeting full inclusion criteria  
(n = 1) 
Studies meeting criteria with 
cholesterol data requirement set aside 
(n = 7) 
Studies available to 1983 dietary 
committee, with no data conducive to 
meta-analysis (n = 6); studies rejected 
for no CHD mortality data (n = 5); 
studies rejected for no serum 
cholesterol data (n = 6). 
Total (n = 17) 
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Table 1 Outcome data from prospective cohort studies for: study name; participant number, gender 
and age range; years of follow-up; total fat and saturated fat for CHD deaths vs. CHD-free. 
Study 
Men/Women 
/Age 
CHD-
free? 
Follow-
up yrs 
CHD 
deaths 
Total fat 
CHD death/Non 
Sat fat 
CHD death/Non 
Kushi et al, 
Ireland Boston 
study[27] (1985) 
1,001 M 
(30-69) 
N 20 110 
39.4/38.5 
% energy (*) 
17.4/16.9 
% energy (*) 
Ascherio et al, 
US Health 
Professionals[28] 
(1996) 
43,757 M 
(40-75) 
Y 6 229 
Note 1 
1.59 (1.01 - 2.51) 
(p=0.02) 
Note 1 
2.21 (1.38 - 3.54) 
(p=0.0016) 
Esrey et al,  
Lipid Research 
[29] (1996) 
 
2,071 M  
1,854 W 
(30-59) 
Y 12 52 
Note 2a 
1.04 (1.01 - 1.08) 
(p<0.01) 
Note 2a 
1.11 (1.04 - 1.18) 
(p<0.01) 
282 M  
339 W 
(60-79) 
Y 12 40 
Note 2a 
1.00 (0.96 - 1.04) 
(p<0.01) (*) 
Note 2a 
0.97 (0.89-1.05) 
(p<0.01) (*) 
Pietinen et al, 
The Finnish 
Cancer Study 
[30] (1997) 
21,930 M 
(50-69) 
Y (all 
smokers) 
6.1 635 
Note 1 
0.85 (0.65 - 1.12) 
(*) 
Note 1 
0.73 (0.56 - 0.95) 
(p= 0.044) 
Boniface & 
Tefft,  
UK Health 
Survey[21] 
(2002) 
1,225 M 
 (40-75) 
Y 16 98 
Note 2b 
1.01 (0.93 - 1.10) 
(*) 
Note 2b 
1.00 (0.86 - 1.18) 
 (*) 
1,451 W 
(40-75) 
Y 16 57 
Note 2b 
1.19 (1.03 - 1.37) 
 (p= 0.0181) 
Note 2b 
1.40 (1.09 - 1.79) 
 (p= 0.0074) 
Xu et al,  
Strong Heart 
Study[31]  
(2006) 
 
646 M 
1,013 W 
(47-59) 
Y 7.2 46 
Note 3 
3.57 (1.21 - 10.49) 
 (p= 0.01) 
Note 3 
5.17 (1.64 - 16.36) 
 (p= 0.01) 
405 M 
874 W 
(60-79) 
Y 7.2 92 
Note 3 
0.77 (0.41 - 1.45) 
 (*) 
Note 3 
0.80 (0.41 - 1.54) 
 (*) 
Nagata et al, 
Japanese 
Study[32] (2012) 
12,953 M 
(>=35) 
Y 16 665 
Notes 1 & 4 
1.12 (0.80 - 1.57) 
(*) 
Notes 1 & 4 
0.96 (0.67 - 1.39) 
(*) 
TOTAL 89,801   2,024   
 
Table notes: (*) Not statistically significant 
95% confidence intervals in parentheses. 
Note 1: Data were presented in quintiles. The lowest quintile fat intake was given a risk ratio (RR) 
for CHD mortality of 1.0. The RR for the highest fat intake, quintile 5, was presented. 
Note 2: 2a) This presented the RR for a one unit increase in the percentage of energy intake 
provided by the nutrient.[29] 2b) This was defined as an additional 100 grams per week.[21] 
Note 3: Data were presented in quartiles. The lowest quartile fat intake was given a risk ratio (RR) 
for CHD mortality of 1.0. The RR for the highest fat intake, quartile 4, was presented. 
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Note 4: Data are for cardiovascular disease (CVD), not CHD. Nagata et al included 15,403 women, 
but did not report on CVD, or CHD mortality by fat intake for women (table 4, p.1718 for 
men)[32]. 
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Fig. 2 Methodological quality summary: review authors’ judgements about each methodological 
quality item for each included study.[38] 
 
 
 
 
 
Results: Meta-analysis 
Participants and Study Design 
The seven prospective cohort studies in Table 1 included 89,801 participants. 84,270 of the 
participants were male (94%). All but one study excluded people with previous heart disease.[27] 
This study could not be included in the meta-analysis, as it did not contain suitable data. The age 
ranges varied from 30 to 79 years old at baseline. Xu et al grouped subjects from 47 to 59 years old 
and from 60 to 79 years old.[31] No explanation was given for this grouping. Esrey et al grouped 
subjects from 30 to 59 years old and from 60 to 79 years old.[29] The rationale for this arbitrary 
classification was reported as to maximise deaths in each group. 
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Participants were followed for a minimum of 6 years and a maximum of 20 years. The mean 
duration of the seven cohorts was 11.9 ± 5.6 years. The weighted mean duration (person years by 
participants) was 8.3 ± 1.1 years. 
All trials had complete outcome data, avoiding attrition bias (Fig. 2).[38] One study was judged 
unclear for selection bias, as participants excluded non-smokers.[30] Four studies were judged 
unclear for detection bias, as blinding of outcome assessment was unclear.[27 30-32] Risk of 
reporting bias was judged low for four of the studies: it was judged unclear for The Strong Heart 
Study and The Lipid Research Study, as the rationale for the age group divisions were not clear;[29 
31] and it was judged high risk for the Japanese Study as CVD by fat intake was researched, but not 
reported, for women.[32] (Fig. 2) 
For total fat and CHD deaths, Esrey et al carried the greatest weight, 31.76% for the 30 to 59 age 
group and 29.45% for the 60 to 79 age group (Fig. 3 random effects methodology).[29] The two 
Boniface and Tefft observations, for men and women, carried a combined weight of 30.04%.[21] 
The two Xu et al observations carried a weight of 1.02% between them.[31] The risk ratio for the 
meta-analysis of the eight data sets available for total fat and CHD deaths was 1.04 (95% CI 0.98 to 
1.10). The overall effect measurement lies on the line of no effect. There was no statistically 
significant difference between total fat and CHD deaths. 
The meta-analysis for total fat and CHD deaths was tested for sensitivity analysis of the exclusion 
of any one study. There were no circumstances in which the exclusion of any one study made the 
overall effect size significant. 
There was evidence for between study heterogeneity. The Q-value was 18.218 (8 df) and this was 
statistically significant p = 0.020. I² was 56.087 and T² was 0.002 indicating difference in true 
effects. 
Visual inspection of the funnel plot revealed that one study was outside the standard error funnel for 
the meta-analysis of total fat and CHD deaths. This was the Xu et al study for people aged 47-
59,[31] which was substantially different from other risk ratios. The Egger’s regression test 
indicated no statistically significant asymmetry for total fat and CHD deaths. The Egger's regression 
intercept was 0.640 (95% CI, two-tailed, -0.959 to 2.238), but this was not statistically significant 
(one-tailed p = 0.188; two-tailed p = 0.376). 
For saturated fat and CHD deaths, Esrey et al carried the greatest weight, 19.83% for the 30 to 59 
age group and 19.28% for the 60 to 79 age group (Fig. 4 random effects methodology).[29] The two 
Boniface and Tefft observations, for men and women, carried a combined weight of 28.96%.[21] 
The two Xu et al observations carried a weight of 5.10% between them.[31] The risk ratio for the 
meta-analysis of the eight data sets available for saturated fat and CHD deaths was 1.08 (95% CI 
0.94 to 1.25). The overall effect measurement lies on the line of no effect. There was no statistically 
significant difference between saturated fat and CHD deaths. 
The meta-analysis for saturated fat and CHD deaths was tested for sensitivity analysis of the 
exclusion of any one study. There were no circumstances in which the exclusion of any one study 
made the overall effect size significant. 
There was evidence for between study heterogeneity. The Q-value was 37.080 (8 df) and this was 
statistically significant p < 0.001. I² was 78.425 and T² was 0.025 indicating difference in true 
effects.  
Visual inspection of the funnel plot revealed that three studies were outside the standard error 
funnel for the meta-analysis of total fat and CHD deaths[28 30] and the Xu et al study for people 
aged 47-59.[31] The Egger’s regression test indicated no statistically significant asymmetry for 
saturated fat and CHD deaths. The Egger's regression intercept was 0.686 (95% CI, two-tailed, -
1.978 to 3.351), but this was not statistically significant (one-tailed p = 0.281; two-tailed p = 0.562). 
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Fig. 3 Estimates of CHD mortality and total fat risk ratios (95% confidence intervals) from meta-
analysis. 
Study name Statistics for each study Risk ratio and 95% CI
Risk Lower Upper 
ratio limit limit Z-Value p-Value
Ascherio (1996) 1.590 1.009 2.507 1.997 0.046
Esrey aged 30-59 (1996) 1.040 1.010 1.070 2.664 0.008
Esrey aged 60-79 (1996) 1.000 0.961 1.041 0.000 1.000
Pietinen (1997) 0.850 0.648 1.116 -1.171 0.242
Boniface men (2002) 1.010 0.929 1.098 0.232 0.816
Boniface women (2002) 1.190 1.032 1.372 2.390 0.017
Xu aged 47-59 (2006) 3.570 1.212 10.511 2.310 0.021
Xu aged 60-79 (2006) 0.770 0.409 1.448 -0.811 0.417
Nagata (2012) 1.120 0.799 1.569 0.659 0.510
1.038 0.982 1.098 1.324 0.185
0.01 0.1 1 10 100
Lower risk with total fat Higher risk with total fat
CHD Deaths & Total Fat Risk Ratios
Meta Analysis random effects method
 
 
 
Fig. 4 Estimates of CHD mortality and saturated fat risk ratios (95% confidence intervals) from 
meta-analysis. 
 
Study name Statistics for each study Risk ratio and 95% CI
Risk Lower Upper 
ratio limit limit Z-Value p-Value
Ascherio (1996) 2.210 1.380 3.540 3.300 0.001
Esrey aged 30-59 (1996) 1.110 1.042 1.182 3.239 0.001
Esrey aged 60-79 (1996) 0.970 0.893 1.054 -0.722 0.470
Pietinen (1997) 0.730 0.560 0.951 -2.334 0.020
Boniface men (2002) 1.000 0.854 1.171 0.000 1.000
Boniface women (2002) 1.400 1.092 1.794 2.659 0.008
Xu aged 47-59 (2006) 5.170 1.637 16.329 2.800 0.005
Xu aged 60-79 (2006) 0.800 0.413 1.550 -0.661 0.509
Nagata (2012) 0.960 0.667 1.383 -0.219 0.826
1.083 0.941 1.247 1.116 0.265
0.01 0.1 1 10 100
Lower risk with saturated fat Higher risk with saturated fat
CHD Death & Saturated Fat Risk Ratios
Meta Analysis random effects method
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Examination of the dietary guidelines 
None of the seven cohort studies examined either of the introduced dietary guidelines: a total fat 
consumption of 30%, or a saturated fat consumption of 10%, of energy intake. Two studies 
examined the total fat intake and the saturated fat intake, as a percentage of calorie intake, for 
participants who died from CHD compared with those who did not.[27 29] Esrey et al also reported 
the risk ratio for an additional one unit of total or saturated fat as a percentage of energy intake. 
Three studies measured total and saturated fat intake in quintiles and reported data for CHD 
mortality as risk ratios comparing the lowest and highest quintiles of intake.[28 30 32] The Strong 
Heart Study followed this method, but for quartiles, not quintiles.[31] The remaining study reported 
the risk ratio for an additional 100 grams of total or saturated fat per week for men and women 
separately.[21] 
CHD mortality 
Across 7 studies, involving 89,801 participants, there were 2,024 deaths from CHD during the 
period of follow-up. The death rate from CHD was 2.25%, during the mean follow-up of 11.9 ± 5.6 
years. The death rate was influenced by the large Finnish study, which included only participants 
who smoked. The death rate for this study was 2.9%. 
The death rate contrasts with the 30% death rate for the six RCTs reviewed in Harcombe et al[3], 
which reinforced the high death rate in secondary studies. The one study that included men with 
previous heart disease reported a death rate of 11%.[27] 
Significance reported by the studies 
Three of the seven studies reported some participants separately: two by age groups[29 31] and one 
by gender.[21] This enabled 10 sets of data to be examined (nine in meta-analysis) (Table 1). Six 
found no significant relationship between total fat and CHD mortality,[27 30 32] men in the UK 
health and lifestyle survey[21] men and women aged 60 to 79 years in The Lipid Research 
Study[29] and the participants aged 60 to 79 years from The Strong Heart Study.[31] The remaining 
four found a significant relationship between total fat and CHD mortality: Ascherio et al;[28] 
women in the UK health and lifestyle survey;[21] and the < 60 year old participants from The Lipid 
Research and The Strong Heart Study.[29 31]Five found no significant relationship between 
saturated fat and CHD mortality;[27 32] men in the UK health and lifestyle survey;[21] and the 
participants aged 60 to 79 years from The Lipid Research and The Strong Heart Study.[29 31]The 
remaining five found a significant relationship between saturated fat and CHD mortality;[28-30] 
women in the UK health and lifestyle survey;[21] and the under 60 year old participants in The 
Lipid Research and The Strong Heart Study.[29 31] 
Meta-analysis confirmed that the pooled data were not significant for CHD mortality and total fat 
intake or CHD mortality and saturated fat intake. 
Serum cholesterol levels 
The only study to meet the full systematic review inclusion criteria was Esrey et al.[29] This study 
found a significant relationship between baseline serum cholesterol and subsequent mortality from 
CHD in the age group 30 to 59 years, but not in the age group 60-79 years old. 
Discussion 
The main findings of this systematic review and meta-analysis are that the epidemiological 
evidence currently available to the dietary committees provides no statistically significant 
retrospective support for the introduction of dietary fat guidelines. 
Most studies reported other significant findings: Kushi et al found a significant association with 
higher intake of carbohydrate and fiber and lower CHD mortality. Esrey et al found significant 
positive associations with age, male gender, Body Mass Index (BMI), smoking and CHD deaths. 
Two studies reported significant associations with trans fat intake and CHD mortality.[28 30] 
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Pietinen et al additionally reported significant associations with the number of cigarettes smoked 
per day, the number of years of smoking, blood pressure, BMI and CHD mortality. Pietinen et al 
found that High Density Lipoprotein (HDL) cholesterol, education and physical activity were 
inversely related to the risk of CHD. Ascherio et al found that associations found between dietary 
fat and heart disease were greatly attenuated by adjusting for fibre intake. Boniface and Tefft 
reported that smoking, not exercising and being socially disadvantaged were related to higher 
saturated fat intake and CHD death, which meant that confounding variables could have played a 
part in findings. Xu et al found that age, being male, having diabetes and smoking were all 
significantly associated with CHD deaths. 
Design limitations 
As was found with the review of RCT evidence in Harcombe et al[3 4], the fundamental design 
limitation of epidemiological evidence currently available is that it lacks generalisability. RCT 
evidence available to the dietary guideline committees had studied men with pre-existing heart 
disease;[3] epidemiological evidence available to the dietary guideline committees had studied men 
mostly free from heart disease.[5] One RCT currently available included men and women, without 
previous heart disease, and contained all component parts of the diet-heart hypothesis for 
examination.[42] One prospective cohort study currently available included men and women free 
from heart disease and contained all component parts of the diet-heart hypothesis for 
examination.[29] 
The method of extracting dietary information was a limitation. Dietary recall is generally unreliable 
and 24-hour recall may not be representative of usual diet.[43 44] Dietary surveys, where food is 
weighed at the time of being recorded, are also unreliable.[45 46] 
Study conclusions 
Two studies concluded that evidence was strong for an association between dietary fat and death 
from CHD. Boniface and Tefft reported: “Strong evidence was found for the within cohort 
relationship of dietary fat and CHD death in women while no evidence was found for a relationship 
in men” (p.786).[21] Xu et al found that: “Total fat, saturated fatty acid, and monounsaturated fatty 
acid intake were strong predictors of CHD mortality in American Indians aged 47-59 y” 
(p.894).[31] 
The Japanese Study found: “Total fat intake is associated with decreased mortality in Japanese men 
but not in women” (p.1713).[32] 
Two studies reported weak or no associations between dietary fat and CHD mortality. Ascherio et 
al appeared to reference The Seven Countries Study with their comment, “These data do not 
support the strong association between intake of saturated fat and risk of coronary heart disease 
suggested by international comparisons” (p.84).[28] Pietinen et al reported that “There was a 
significant positive association between the intake of trans fatty acids and the risk of coronary 
death. There was no association between intakes of saturated or cis-monounsaturated fatty acids or 
linoleic or linolenic acid or dietary cholesterol and the risk of coronary death” (p.876).[30] 
The final two studies described the relationship as unclear. Kushi et al concluded: “The nature of 
the association in this study between dietary lipids and the risk of mortality from coronary heart 
disease remains unclear” (p.816).[27] The one study meeting all systematic review inclusion criteria 
reported: “We conclude that future research must be directed toward better understanding the 
pathway between dietary intake and coronary disease as the current diet-lipid-heart hypothesis may 
be overly simplistic” (p.211).[29] 
Other meta-analyses of prospective cohort studies 
The aim of this systematic review, as part of a series of four, [3-5] has been to evaluate the RCT and 
prospective cohort evidence base for two specific dietary fat guidelines (30% and 10% of energy 
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intake in the form of total and saturated fat respectively) at their time of introduction and the present 
day. This has not previously been undertaken.  
A number of other systematic reviews and meta-analyses have been undertaken, which are relevant 
to the present review.[34-36 47] De Souza et al[47] systematically reviewed saturated, not total, fat 
including any observational study, not just prospective cohort studies, with mortality as the end 
point. Siri-Tarino et al[34] undertook a meta-analysis of prospective cohort studies for saturated, 
not total, fat, with disease as the end point. Chowdhury et al[36] also examined saturated, not total, 
fat and with disease, not mortality, as the end point, including RCTs and prospective cohort studies 
in the same review. Skeaff and Miller[35] were closest to this review, and the one reviewing RCTs 
currently available,[4] having undertaken a systematic review and meta-analysis of RCTs and 
prospective cohort studies combined, for total and saturated fat, with CHD end points, disease and 
mortality. This was published in 2009. 
De Souza et al concluded: “Saturated fats are not associated with all cause mortality, CVD, CHD, 
ischemic stroke, or type 2 diabetes, but the evidence is heterogeneous with methodological 
limitations” (p.1).[47]  
The conclusion of Siri-Tarino et al’s review was “meta-analysis of prospective epidemiologic 
studies showed that there is no significant evidence for concluding that dietary saturated fat is 
associated with an increased risk of CHD or CVD” (p.535).[34] 
Chowdhury et al set out to summarise evidence between fatty acids and coronary disease. Their 
review examined saturated, monounsaturated, polyunsaturated and trans fats, while also reviewing 
individual chain length fatty acids, palmitic (C16:0) and margaric (C17:0) as examples. The 
conclusion was “Current evidence does not clearly support cardiovascular guidelines that encourage 
high consumption of polyunsaturated fatty acids and low consumption of total saturated fats” 
(p.398) [36]. 
Skeaff and Miller sought to summarise the evidence from cohort studies and RCTs of the relation 
between dietary fat and risk of CHD. Their conclusion was “Intake of total fat was not significantly 
associated with CHD mortality. Intake of total fat was also unrelated to CHD events” (p.175) [35].  
Harcombe et al[3 5] found that the dietary fat guidelines were not supported by RCT or 
epidemiological evidence available at the time of their introduction. These dietary fat guidelines 
have prevailed until 2016 and thus the validity of their evidence base remains important to examine. 
UK dietary fat guidelines are unchanged. The Dietary Guidelines for Americans, issued in January 
2016,[48] were conspicuously silent on the subject of total fat, but reiterated that saturated fat 
should be restricted to no more than 10% of calorie intake. Harcombe et al[4] found that the RCT 
evidence currently available does not support the dietary fat guidelines. This review finds that the 
epidemiological evidence currently available does not support the dietary fat guidelines. All 
systematic reviews found serious limitations with the availability of primary prevention, both-sex, 
studies, which are the ones most likely to have generalisability for whole populations. 
The conclusion of the four systematic reviews and three meta-analyses is that there was no evidence 
to support the dietary fat guidelines being introduced and there is no evidence currently available to 
support them. Public health authorities need to urgently review dietary advice.  
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